DMARD

DRUG5 trials

Sponsors

Amgen, Charite University, Berlin, Germany, Hoffmann-La Roche, Barts & The London NHS Trust

Conditions

Arthritis, RheumatoidReactive ArthritisRheumatoid ArthritisUltrasonography

Phase 2

New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

Charite University, Berlin, GermanyReactive Arthritis

Start: 2003-01-31Target: 40Updated: 2006-09-08

Phase 3

A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid Arthritis

CompletedNCT01995201

Hoffmann-La RocheRheumatoid Arthritis

Start: 2013-09-30End: 2016-03-31Updated: 2018-01-26

Phase 4

A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis

TerminatedNCT01251120

Hoffmann-La RocheRheumatoid Arthritis

Start: 2011-11-30End: 2013-01-31Updated: 2014-11-11

Unknown Phase

Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

CompletedNCT00116714

AmgenRheumatoid Arthritis

Start: 2001-10-31End: 2008-10-31Updated: 2011-05-06

Ultrasound Utility in Routine Clinical Practise

CompletedNCT03124225

Barts & The London NHS TrustArthritis, Rheumatoid, Ultrasonography

Start: 2011-06-30End: 2013-06-30Updated: 2017-04-21

Related Papers

Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis

Lara D. Veeken2018-11-2110 citations

Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries

Lara D. Veeken2017-10-3137 citations

Rheumatoid arthritis disease-modifying antirheumatic drug intervention and utilization study: safety and etanercept utilization analyses from the RADIUS 1 and RADIUS 2 registries.

2010-10-1518 citations